Notifiable Conditions

Report Immediately

  • Amebic meningitis
  • Anthrax
  • Botulism (foodborne, wound, infant)
  • Burkholderia mallei (Glanders) and pseudomallei (Melioidosis)
  • Cholera
  • Coronavirus infection (SARS, MERS, COVID-19)
  • Diphtheria
  • Domoic acid poisoning (amnesic shellfish poisoning)
  • Haemophilus influenzae (invasive disease) (children under 5 years old)
  • Influenza (novel or unsubtypable strain)
  • Measles (rubeola) (acute)
  • Meningococcal disease (invasive)
  • Mpox
  • Outbreak (suspected foodborne or waterborne origin)
  • Paralytic shellfish poisoning
  • Pesticide poisoning (hospitalized, fatal, cluster)—Call (800) 222-1222.
  • Plague
  • Poliomyelitis
  • Rabies (confirmed human or animal) (suspected human exposure)
  • Rubella (including congenital rubella syndrome) (acute)
  • Shiga toxin-producing E. coli infections (including but not limited to E. coli O157:H7)
  • Smallpox
  • Suspected institutional outbreak of any illness (e.g., influenza-like illness, gastro-intestinal symptoms)
  • Tularemia
  • Vaccinia transmission
  • Viral hemorrhagic fever
  • Yellow fever

Report Within 24 Hours

  • Baylisascariasis
  • Brucellosis
  • Candida auris infection or colonization
  • Hantavirus infection
  • Hepatitis A (acute)
  • Hepatitis B (acute)
  • Hepatitis C (acute)
  • Hepatitis C (perinatal)
  • Hepatitis D (acute or chronic)
  • Hepatitis E (acute)
  • Legionellosis
  • Leptospirosis
  • Listeriosis
  • Mumps (acute)
  • Pertussis
  • Psittacosis
  • Q fever
  • Salmonellosis
  • Shigellosis
  • Tuberculosis (confirmed or highly suspicious)
  • Vancomycin-resistant Staphylococcus aureus (not vancomycin-intermediate)
  • Vibriosis
  • Yersiniosis
  • Unexplained critical illness or death

Report Within 3 Business Days

  • Acquired immunodeficiency syndrome (AIDS) (including people previously reported with HIV)
  • Anaplasmosis
  • Arboviral disease (acute) (including, but not limited to, chikungunya, dengue, eastern and western equine encephalitis, Japanese encephalitis, LaCrosse encephalitis, Powassan virus, St. Louis encephalitis, West Nile virus, Zika virus)
  • Babesiosis
  • Campylobacteriosis
  • Carbapenem-resistant Enterobacteriaceae infections (limited to Klebsiella species, E. coli, Enterobacter species)
  • Chagas disease
  • Chancroid
  • Chlamydia trachomatis infection
  • Coccidioidomycosis
  • Cryptococcus gattii or undifferentiated Cryptococcus species (e.g., Cryptococcus not identified as C. neoformans)
  • Cryptosporidiosis
  • Cyclosporiasis
  • Cysticercosis
  • Echinococcosis
  • Ehrlichiosis
  • Giardiasis
  • Gonorrhea
  • Granuloma inguinale
  • Hepatitis B surface antigen positive pregnant women
  • Hepatitis B (chronic) (initial diagnosis and previously unreported cases)
  • Hepatitis B (perinatal) (initial diagnosis)
  • Hepatitis C (chronic)
  • Herpes simplex (neonatal and genital) (initial diagnosis)
  • Histoplasmosis
  • HIV infection
  • Human prion disease
  • Immunization reactions (severe, adverse)
  • Influenza-associated death (lab confirmed)
  • Lyme disease
  • Lymphogranuloma venereum
  • Malaria
  • Pesticide poisoning (non-hospitalized, non-fatal, non-cluster)—Call (800) 222-1222.
  • Relapsing fever (borreliosis)
  • Rickettsia infection
  • Syphilis (including congenital)
  • Taeniasis
  • Tetanus
  • Tick paralysis
  • Trichinosis
  • Typhus
  • Varicella-associated death

Report Within 7 Business Days

  • Tuberculosis infection (latent) (positive tuberculosis skin test or interferon-gamma release assay, e.g., QuantiFERON®-TB Gold)

Report Monthly